Brief: Quotient Limited Announces CE Mark For Its Sars-Cov-2 (Covid-19) Antibody Microarray
01/05/2020 21:56
May 1 (Reuters) - Quotient Ltd QTNT.O :
* QUOTIENT LIMITED ANNOUNCES CE MARK FOR ITS SARS-COV-2
(COVID-19)
ANTIBODY MICROARRAY
* QUOTIENT LTD - MOSAIQ COVID-19 ANTIBODY MICROARRAY IS
DESIGNED
AS A SEROLOGICAL DISEASE SCREEN SPECIFIC TO COVID-19
Source text for Eikon: ID:nGNXbBRW7Y
Further company coverage: QTNT.O
((Briefs@thomsonreuters.com;))
Recent news on Quotient
See all newsBrief: Quotient Ltd Enters Into Amended And Restated Transaction Support Agreement
U.S. STOCKS ON THE MOVE-Tesla, Exxon Mobil, Chevron
Quotient down on plans to delist from Nasdaq
Brief: Quotient Limited Announces Intent To Voluntary Delist From The Nasdaq Global Market
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem